Platelet antibodies and fetal growth: Maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 1, 2012, Pages 79-86

  Tiller, Heidi ^a   Killie, Mette Kjær ^a   Husebekk, Anne ^a,b   Skogen, Bjørn ^a,b   Ni, Heyu ^c,d   Kjeldsen Kragh, Jens ^e,f   Øian, Pål ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

Anti HPA 1a antibodies; birthweight; fetal and neonatal alloimmune thrombocytopenia; fetal sex; small for gestational age

Indexed keywords

MATERNAL ANTIBODY; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN;

ADULT; ALLOIMMUNIZATION; ARTICLE; BIRTH WEIGHT; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FETUS; FETUS GROWTH; GESTATIONAL AGE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; OBSERVATIONAL STUDY; PARITY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING HABIT; UNIVERSITY HOSPITAL; WEIGHT REDUCTION;

ADULT; ANTIGENS, HUMAN PLATELET; BIRTH WEIGHT; BLOOD GROUP INCOMPATIBILITY; COHORT STUDIES; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; ISOANTIBODIES; LINEAR MODELS; LOGISTIC MODELS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 83455195337     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2011.01269.x     Document Type: Article

References (30)

1. Kjeldsen-Kragh J, Killie MK, Tomter G, Golebiowska E, Randen I, Hauge R, et al,. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood. 2007; 110: 833-9. (Pubitemid 47267418)
2. Kamphuis MM, Paridaans N, Porcelijn L, de Haas M, van der Schoot CE, Brand A, et al,. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. Br J Obstet Gynaecol. 2010; 117: 1335-43.
3. Kanhai HH, Porcelijn L, Engelfriet CP, Reesink HW, Panzer S, Ulm B, et al,. Management of alloimmune thrombocytopenia. Vox Sang. 2007; 93: 370-85. (Pubitemid 350135084)
4. Kjeldsen-Kragh J, Husebekk A, Killie MK, Skogen B,. Is it time to include screening for neonatal alloimmune thrombocytopenia in the general antenatal health care programme? Transfus Apher Sci. 2008; 38: 183-8.
5. Hynes RO,. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992; 69: 11-25.
6. Ni H, Freedman J,. Platelets in hemostasis and thrombosis: role of integrins and their ligands. Transfus Apher Sci. 2003; 28: 257-64. (Pubitemid 36506500)
7. Kumpel BM, Sibley K, Jackson DJ, White G, Soothill PW,. Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy. Transfusion. 2008; 48: 2077-86.
8. Vanderpuye OA, Labarrere CA, McIntyre JA,. A vitronectin-receptor-related molecule in human placental brush border membranes. Biochem J. 1991; 280: 9-17.
9. Brodsky D, Christou H,. Current concepts in intrauterine growth restriction. J Intensive Care Med. 2004; 19: 307-19. (Pubitemid 44544694)
10. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C,. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood. 1987; 70: 1722-6. (Pubitemid 18055614)
11. Bertrand G, Jallu V, Gouet M, Kjaer KM, Lambin P, Husebekk A, et al,. Quantification of human platelet antigen-1a antibodies with the monoclonal antibody immobilization of platelet antigens procedure. Transfusion. 2005; 45: 1319-23. (Pubitemid 41647797)
12. Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B,. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica. 2008; 93: 870-7. (Pubitemid 351821723)
13. Skjaerven R, Gjessing HK, Bakketeig LS,. Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand. 2000; 79: 440-9. (Pubitemid 30326124)
14. In:, Norusis MJ, (ed). SPSS 16.0 Advanced Statistical Procedures Companion, 1st edn. Upper Saddle River, NJ, USA: Prentice Hall Inc. 2008. pp. 195-237.
15. In:, Norusis MJ, (ed). SPSS 16.0 Advanced Statistical Procedures Companion, 1st edn. Upper Saddle River, NJ, USA: Prentice Hall Inc. 2008. pp. 279-97.
16. Vittinghoff E, McCulloch CE,. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007; 165: 710-8. (Pubitemid 46348374)
17. Kvalvik LG, Skjaerven R, Haug K,. Smoking during pregnancy from 1999 to 2004: a study from the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand. 2008; 87: 280-5. (Pubitemid 351317471)
18. Ward C, Lewis S, Coleman T,. Prevalence of maternal smoking and environmental tobacco smoke exposure during pregnancy and impact on birth weight: retrospective study using Millennium Cohort. BMC Public Health. 2007; 7: 81.
19. Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A,. Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab. 2007; 92: 804-10. (Pubitemid 46465644)
20. Strauss RS,. Adult functional outcome of those born small for gestational age: twenty-six-year follow-up of the 1970 British Birth Cohort. J Am Med Assoc. 2000; 283: 625-32. (Pubitemid 30069178)
21. Sheiner E, Levy A, Katz M, Hershkovitz R, Leron E, Mazor M,. Gender does matter in perinatal medicine. Fetal Diagn Ther. 2004; 19: 366-9. (Pubitemid 38822759)
22. Ulm B, Svolba G, Ulm MR, Bernaschek G, Panzer S,. Male fetuses are particularly affected by maternal alloimmunization to D antigen. Transfusion. 1999; 39: 169-73. (Pubitemid 29085138)
23. Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, et al,. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet. 1989; i: 363-6. (Pubitemid 19103082)
24. Althaus J, Weir EG, Askin F, Kickler TS, Blakemore K,. Chronic villitis in untreated neonatal alloimmune thrombocytopenia: an etiology for severe early intrauterine growth restriction and the effect of intravenous immunoglobulin therapy. Am J Obstet Gynecol. 2005; 193: 1100-4. (Pubitemid 41285501)
25. Labarrere CA, Althabe OH,. Intrauterine growth retardation of unknown etiology: II. Serum complement and circulating immune complexes in maternal sera and their relationship with parity and chronic villitis. Am J Reprod Immunol Microbiol. 1986; 12: 4-6. (Pubitemid 16001718)
26. Brooks PC, Clark RA, Cheresh DA,. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 1994; 264: 569-71.
27. Enenstein J, Kramer RH,. Confocal microscopic analysis of integrin expression on the microvasculature and its sprouts in the neonatal foreskin. J Invest Dermatol. 1994; 103: 381-6. (Pubitemid 24329761)
28. van Gils JM, Stutterheim J, van Duijn TJ, Zwaginga JJ, Porcelijn L, de Haas M, et al,. HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrity. Mol Immunol. 2009; 46: 406-15.
29. Italiano JE Jr, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, et al,. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood. 2008; 111: 1227-33. (Pubitemid 351213404)
30. Ho-Tin-Noe B, Goerge T, Cifuni SM, Duerschmied D, Wagner DD,. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res. 2008; 68: 6851-8.